Vitamins and Food Supplements
0 items$0.00

No products in the cart.



Probiotics must survive stomach acid before they can get to your intestine where they live.

Probiotic-Medical is patented and proven to be acid and bile resistant.  Our patented process both shields and stabilizes the good flora.  How do we do it?  We use special stabilizers as well as “cryoprotect” these good bacteria with proprietary agents.  As a result, our probiotic organisms are protected and stable.  That’s not all, clinical analysis of many of these good bacteria have been proven to bind to the intestine wall where they can live, thrive and do their jobs.

Out of stock


Probiotics must survive stomach acid before they can get to your intestine where they live.

Probiotic-Medical is patented and proven to be acid and bile resistant.  Our patented process both shields and stabilizes the good flora.  How do we do it?  We use special stabilizers as well as “cryoprotect” these good bacteria with proprietary agents.  As a result, our probiotic organisms are protected and stable.  That’s not all, clinical analysis of many of these good bacteria have been proven to bind to the intestine wall where they can live, thrive and do their jobs. 



Probiotics work by their ability to compete with bad microorganisms for sites to live.  They antagonize these bad pathogens and help your immune system and more.  Of course they can only help you if they are alive.  In Probiotic-Medical you get 30 Billion beneficial organisms in just two capsules.  You also get additional benefits of prebiotic fructooligosaccharides for immune health and gastrointestinal support. †

Oral supplements of live, beneficial intestinal microorganisms for nutritional health and well-being are known as probiotics. Probiotic dietary lactobacilli colonize the intestinal tract. Bacteria are continually in competition for colonization space. The original bacterial colonies have an advantage over transient bacteria. Nevertheless, the composition of the intestinal microflora is dynamic and constantly changing. If harmful microorganisms proliferate, the equilibrium is disturbed, and it becomes difficult even for indigenous bacteria to maintain their necessary territory to colonize the intestine. Antibiotics tend to kill off both beneficial and harmful bacteria, and thus may also disturb the normal, healthy balance of intestinal microorganisms. Various intestinal conditions can compromise the immune system and lower the amounts of healthy intestinal microflora. When potent probiotic supplements, such as Probiotic-Medical, are supplied regularly, chances are greatly increased for establishing and maintaining a healthy population of beneficial intestinal microorganisms†. Once established, a normal intestinal microflora rich in lactobacilli creates acidic conditions that are unfavorable for the settlement of pathogenic microorganisms. Probiotics have been shown to exert a beneficial support through modification of the immune system host via the gut environment.

Bifidobacterium lactis HN019 has been clinically shown in research to support the immune system by enhancing the function of leucocytes in adults and the elderly.† This strain may also help in the maintenance of bowel regularity and normal GI function.†

Clinical trials also suggest that the exposure to microbes through the gastrointestinal tract powerfully shapes immune function. In particular, lactobacilli are considered to induce reactions involvingTh1 cells that benefit allergic diseases. Research on the L. gasseri strain supplementation has shown a beneficial effect on immunological reactions in school children. Lactobacillus rhamnosus is one of the most widely studied probiotics, noted and valued for its ability to survive in the harsh conditions of the digestive and urinary tracts. L. rhamnosus is extremely well tolerated by men and women with very rare side effects. Studies have shown that, taken regularly, L. rhamnosus can be an effective supplement in promoting and maintaining digestive tract health. Probiotic-Medical is acid and bile resistant and the cultures undergo a patented cyroprotectant stabilization process for shelf stability. For example, Bifidobacterium was studied in vitro to be extremely resistant to low pH and bile acids in the duodenum. L. acidophilus DDS-1incorporates proprietary cryoprotectant agents and stabilizers specifically designed to protect the organism and enhance stability.

Clinical analysis of DDS-1 and Bifidobacterium also shows increased binding to human intestinal walls and protective effects of intestinal colonization. Certain bacterial acids in the intestines produce secondary bile acids, which have been implicated as promoters of colon carcinogenesis. One study indicated that L. acidophilus DDS-1 decreased the potential for bacterial transformations of primary bile acid. Prebiotics are carbohydrates that have short molecular chains. They function as non-digestible ingredients that can positively affect selected groups of beneficial intestinal microflora, such as lactobacillus. While probiotics merely add beneficial microflora, prebiotics affect the intestinal environment so that beneficial colonies of microflora can flourish. By aiding the beneficial microflora’s survival, pathogenic microflora can have a decreased chance of survival.


Probiotic-Medical capsules may be a useful dietary supplement for those who wish to support their intestinal microflora with potent amounts of beneficial microorganisms.

Supplement Facts

  • Serving Size – 1-2 Capsules
  • Servings Per Container – 60

Other Ingredients

Gelatin (capsule), cellulose, vegetable stearate and silica.

This product contains NO yeast, wheat, gluten, soy protein, corn, sodium, starch, artificial coloring, preservatives or flavoring.

Suggested Usage

As a dietary supplement, adults take 1-2 capsules daily or as directed by your healthcare professional.


For optimal storage conditions, keep refrigerated with lid tightly sealed after opening.Tamper resistant package, do not use if outer seal is missing.


  • Milk
  • Multi-Strain Probiotic Blend 15 Billion CFU *
    • Lactobacillus acidophilus (DDS-1) 4.3 Billion CFU *
    • Lactobacillus rhamnosus (Lr-32) 4.3 Billion CFU *
    • Bifidobacterium lactis (HN019) 1.9 Billion CFU *
    • Lactococcus lactis (Ll-23) 1.0 Billion CFU *
    • Bifidobacterium longum (Bl-05) 1.0 Billion CFU *
    • Bifidobacterium bifidum (Bb-02) 1.0 Billion CFU *
    • Lactobacillus gasserri (Lg-36) 1.0 Billion CFU *
    • Streptococcus thermophilus (St-21) 0.5 Billion CFU *
    • Digestive and Prebiotic Blend 210 mg
    • FOS (fructooligosaccharides) and Ulmus fulva (bark)

* Daily value not established

Adults take one-two capsules daily or as directed by a healthcare professional.


No adverse side effects have been reported.


REFRIGERATE after opening with lid tightly sealed.

Keep out of reach of children.


  • Rerksuppaphol S, Rerksuppaphol L. Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea. Ann Trop Paediatr. 2010;30(4):299-304.
  • Mondot S, Kang S, Furet JP, Aguirre de Carcer D, McSweeney C, Morrison M,Marteau P, Doré J, Leclerc M. Highlighting new phylogenetic specificities of Crohn’s disease microbiota. Inflamm Bowel Dis. 2010 Aug 18.
  • Hong KS, Kang HW, Im JP, Ji GE, Kim SG, Jung HC, Song IS, Kim JS. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver.2009 Jun;3(2):101-7. Epub 2009 Jun 30.
  • Sang LX, Chang B, Zhang WL, Wu XM, Li XH, Jiang M. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterolgy. 2010 Apr 21;16(15):1908 -15
  • Robert J Boyle, Roy M Robins-Browne and Mimi LK Tang. Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition, Vol. 83, No. 6, 1256-1264, June 2006
  • Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Therapeutic Advances in Gastroenterology 2010 3: 307-319
  • Rhode CL. The Use of Probiotics in the Prevention and Treatment of Antibiotic- Associated Diarrhea with Special Interest in Clostridium difficile-Associated Diarrhea. Nutr Clin Pract 2009 24: 33-40.
  • Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol. 2010 Nov;45(11):1111-20.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


There are no reviews yet.

Be the first to review “Probiotic-Medical”

Your email address will not be published.